Alembic Pharmaceuticals successfully completed ANVISA GMP inspection at its API-III Facility in Karakhadi.
The Brazilian health regulator conducted the inspection from May 11-15, 2026.
The facility received zero observations for multiple APIs during the inspection.
The company filed this regulatory disclosure with BSE and NSE exchanges.